By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

GenSpera 

9901 IH 10 West
Suite 800
San Antonio  Texas  78230  U.S.A.
Phone: 210-477-8537 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
GenSpera Receives Patent On Prodrug Targeted For Prostate Cancer 9/9/2014 8:12:38 AM
GenSpera Presents Mipsagargin (G-202) HCC Clinical Trial Update At 8th International Liver Cancer Association Conference 9/8/2014 8:56:11 AM
GenSpera Announces Generic Name "Mipsagargin" For Lead Drug Candidate G-202 Per Recommendation By World Health Organization 9/4/2014 2:21:07 PM
GenSpera To Present At Rodman & Renshaw 16th Annual Global Investment Conference 8/14/2014 9:27:17 AM
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer 7/30/2014 8:24:02 AM
Media Advisory: GenSpera's G-202 HCC Clinical Trial Presentation From 5th Asia-Pacific Primary Liver Cancer Expert (APPLE) Meeting Available 7/22/2014 1:29:19 PM
GenSpera Presents G-202 HCC Clinical Trial Update At 5th Asia-Pacific Primary Liver Cancer Expert Meeting 7/15/2014 9:12:27 AM
Kareg Corporation Initiates Coverage On GenSpera With A Speculative Buy Recommendation 7/14/2014 11:05:08 AM
GenSpera Release: Kareg Corporation Initiates Coverage On Genspera With A Speculative Buy Recommendation 7/14/2014 9:37:46 AM
GenSpera To Present Ongoing HCC Trial Data At APPLE 2014 Congress July 12th In Taipei 7/7/2014 9:14:52 AM
12345
//-->